
Marshall Wace’s Larimar Therapeutics LRMR Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-110,304
| Closed | -$427K | – | 2716 |
|
2024
Q4 | $427K | Buy |
110,304
+37,810
| +52% | +$146K | ﹤0.01% | 1962 |
|
2024
Q3 | $475K | Sell |
72,494
-22,720
| -24% | -$149K | ﹤0.01% | 1793 |
|
2024
Q2 | $690K | Sell |
95,214
-4,574
| -5% | -$33.2K | ﹤0.01% | 1661 |
|
2024
Q1 | $757K | Buy |
+99,788
| New | +$757K | ﹤0.01% | 1542 |
|
2023
Q2 | – | Sell |
-58,908
| Closed | -$267K | – | 2281 |
|
2023
Q1 | $267K | Buy |
+58,908
| New | +$267K | ﹤0.01% | 1851 |
|
2022
Q4 | – | Sell |
-38,710
| Closed | -$124K | – | 2604 |
|
2022
Q3 | $124K | Buy |
+38,710
| New | +$124K | ﹤0.01% | 2399 |
|
2022
Q1 | – | Sell |
-11,392
| Closed | -$124K | – | 2997 |
|
2021
Q4 | $124K | Sell |
11,392
-15,195
| -57% | -$165K | ﹤0.01% | 2639 |
|
2021
Q3 | $306K | Buy |
26,587
+2,093
| +9% | +$24.1K | ﹤0.01% | 2066 |
|
2021
Q2 | $240K | Sell |
24,494
-29,620
| -55% | -$290K | ﹤0.01% | 1896 |
|
2021
Q1 | $790K | Buy |
+54,114
| New | +$790K | ﹤0.01% | 1489 |
|
2015
Q2 | – | Sell |
-26,375
| Closed | -$1.05M | – | 977 |
|
2015
Q1 | $1.05M | Buy |
+26,375
| New | +$1.05M | 0.01% | 568 |
|
2014
Q4 | – | Sell |
-84,741
| Closed | -$1.67M | – | 889 |
|
2014
Q3 | $1.67M | Buy |
+84,741
| New | +$1.67M | 0.02% | 476 |
|